Amgen (NASDAQ: AMGN) SVP reports 787 shares withheld for taxes

Rhea-AI Filing Summary

Amgen Inc. senior vice president and chief compliance officer Nancy A. Grygiel reported a routine tax-related share withholding. On March 16, 2026, 787 shares of Amgen common stock were disposed of at $366.21 per share to satisfy tax obligations tied to equity compensation.

After this tax-withholding disposition, she directly holds 8,488 Amgen shares, which include 122 dividend equivalents that will pay out in shares as they vest. She also indirectly holds 106.1873 shares through the company’s 401(k) plan stock fund.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Grygiel Nancy A.

Role SVP & CCO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	787	$366.21	$288K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 8,488 shares (Direct); Common Stock — 106.187 shares (Indirect, 401(k) Plan)

Footnotes (1)

1. These shares include 122 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grygiel Nancy A.

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & CCO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		F		787	D	$366.21	8,488(1)	D
Common Stock								106.1873(2)	I	401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 122 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

2. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.

	/s/ Nancy A. Grygiel	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Amgen (AMGN) SVP Nancy Grygiel report?

Nancy A. Grygiel reported a tax-withholding disposition of 787 Amgen common shares. These shares were used to cover tax obligations related to equity compensation, rather than an open-market sale, and were priced at approximately $366.21 per share in the transaction record.

How many Amgen (AMGN) shares does Nancy Grygiel hold after this Form 4?

Following the reported transaction, Nancy Grygiel directly holds 8,488 Amgen common shares. This direct position includes 122 dividend equivalents that will pay out in stock as they vest. She also indirectly holds 106.1873 shares through the company’s 401(k) plan stock fund.

Was the Amgen (AMGN) insider transaction a sale on the open market?

The filing classifies the 787-share transaction as a tax-withholding disposition, not an open-market sale. Shares were delivered to satisfy tax liabilities arising from equity awards, a routine administrative event that does not reflect a discretionary decision to sell shares on the market.

What does the tax-withholding code F mean in the Amgen (AMGN) Form 4?

Code F indicates shares were disposed of to pay exercise price or tax liabilities tied to equity awards. For Amgen, 787 shares of common stock were used this way, reflecting standard handling of tax obligations on compensation rather than a voluntary buy or sell decision.

How are dividend equivalents treated in Nancy Grygiel’s Amgen (AMGN) holdings?

The filing explains that 122 dividend equivalents are credited to unvested restricted stock units. These are paid out in Amgen common shares on a one-to-one basis as the awards vest, along with a cash payment for any remaining fractional share amount, enhancing eventual share delivery.

What Amgen (AMGN) shares does Nancy Grygiel hold through the 401(k) plan?

Nancy Grygiel indirectly holds 106.1873 Amgen shares through the company’s 401(k) plan. The filing notes these represent interests in the company’s stock fund as of the filing date, reflecting retirement-plan ownership separate from her directly held common stock position.